STAT Plus: With another trial failure, it may be time to revoke the approval of Acadia Pharma?s anti-psychosis drug

STAT Plus: With another trial failure, it may be time to revoke the approval of Acadia Pharma?s anti-psychosis drug

Play Episode Pause Episode

Mute/Unmute Episode Rewind 10 Seconds 1x Fast Forward 30 seconds

00:00 /

RSS Feed

Share

Link

Embed

With another trial failure, it might be time for the FDA to revoke the approval of Acadia Pharma?s anti-psychosis drug.